NBC
BIO icon

Neuberger Berman Canada’s Bio-Rad Laboratories Class A BIO Stock Holding History

Neuberger Berman Canada’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$232K Sell
1,045
-181
-15% -$40.7K 0.04% 293
2017
Q2 		$277K Sell
1,226
-92
-7% -$20K 0.05% 298
2017
Q1 		$263K Buy
+1,318
New +$254K 0.05% 282
2015
Q1 		– Sell
-2,800
Closed -$338K – 190
2014
Q4 		$338K Buy
+2,800
New +$322K 0.05% 214

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Neuberger Berman Canada's BIO Position: Q3 2017 in Review

Neuberger Berman Canada reduced its Bio-Rad Laboratories Class A (BIO) stake by 15% in Q3 2017, selling an estimated $40.7K and leaving 1,045 shares worth $232K. The position accounts for 0.04% of the portfolio, ranked #293.

Neuberger Berman Canada first reported a position in BIO in Q4 2014 and has held it in 4 quarters since. The position peaked at $338K in Q4 2014. 271 funds tracked by Wall St. Rank hold BIO as of Q3 2017.

  • Neuberger Berman Canada held 1,045 shares of Bio-Rad Laboratories Class A worth $232K as of Q3 2017.
  • Neuberger Berman Canada sold 181 Bio-Rad Laboratories Class A shares in Q3 2017, an estimated $40.7K.
  • Bio-Rad Laboratories Class A made up 0.04% of Neuberger Berman Canada's portfolio in Q3 2017, its #293 holding.
  • Neuberger Berman Canada first reported a position in Bio-Rad Laboratories Class A in Q4 2014 and has held it in 4 quarters since.
  • Neuberger Berman Canada's Bio-Rad Laboratories Class A position peaked at $338K in Q4 2014.
  • 271 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2017.

Based on Neuberger Berman Canada's 13F filing for Q3 2017, filed 3 Nov 2017.